# HUNTINGTON BANCSHARES INC /MD/ (HBAN)

Informational only - not investment advice.

CIK: 0000049196
SIC: 6021 National Commercial Banks
SIC breadcrumb: [Finance, Insurance, And Real Estate](/division/H/) > [Depository Institutions](/major-group/60/) > [SIC 6021 National Commercial Banks](/industry/6021/)
Latest 10-K filed: 2026-02-13
SEC page: https://www.sec.gov/edgar/browse/?CIK=49196
Filing source: https://www.sec.gov/Archives/edgar/data/49196/000004919626000015/hban-20251231.htm

## At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-13 · accession 0000049196-26-000015 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000049196.json

| Metric | Value | FY | Provenance |
| --- | ---: | ---: | --- |
| Revenue | 10,310,000,000 USD | 2025 | verified |
| Net income | 2,211,000,000 USD | 2025 | verified |
| Assets | 225,106,000,000 USD | 2025 | verified |
| Free cash flow | 2,215,000,000 USD | 2025 | computed |
| Net margin | 21.45% | 2025 | computed |
| Revenue YoY | +3.92% | 2025 | computed |
| ROE | 9.08% | 2025 | computed |

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

Peer groups: [Regional banks](/compare/regional-banks/) · SIC 6021 National Commercial Banks

No market price, no rating, no forecast on this site. Not investment advice.

## Peer comparisons including HBAN

- Regional banks: [peer review](/compare/regional-banks/) · [market-risk page](/compare/regional-banks/risk/)

### Peer percentile fingerprint

| Ratio | HBAN | Peer median | Percentile | N |
| --- | ---: | ---: | ---: | ---: |
| Net margin | 21.4% | 22.9% | 36 | 76 |
| Revenue growth | 3.9% | 5.2% | 41 | 76 |
| FCF margin | 21.5% | 22.0% | 45 | 65 |
| ROE | 9.1% | 9.9% | 35 | 76 |
| ROA | 1.0% | 1.1% | 39 | 76 |
| Liabilities / equity | 8.25 | 8.12 | 52 | 76 |

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 6021 National Commercial Banks, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

## Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
| --- | ---: | --- | ---: | --- |
| Revenue | 10310000000 | USD | 2025 | 2026-02-13 |
| Net income | 2211000000 | USD | 2025 | 2026-02-13 |
| Assets | 225106000000 | USD | 2025 | 2026-02-13 |

## Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-13. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000049196.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | 2,632,000,000 | 3,433,000,000 | 3,949,000,000 | 4,201,000,000 | 3,647,000,000 | 4,191,000,000 | 5,969,000,000 | 8,916,000,000 | 9,921,000,000 | 10,310,000,000 |
| Net income | 712,000,000 | 1,186,000,000 | 1,393,000,000 | 1,411,000,000 | 817,000,000 | 1,295,000,000 | 2,238,000,000 | 1,951,000,000 | 1,940,000,000 | 2,211,000,000 |
| Diluted EPS | 0.70 | 1.00 | 1.20 | 1.27 | 0.69 | 0.90 | 1.45 | 1.24 | 1.22 | 1.39 |
| Operating cash flow | 1,215,000,000 | 1,954,000,000 | 1,726,000,000 | 1,574,000,000 | 1,323,000,000 | 2,062,000,000 | 4,027,000,000 | 2,657,000,000 | 1,836,000,000 | 2,482,000,000 |
| Capital expenditures | 120,000,000 | 194,000,000 | 110,000,000 | 107,000,000 | 119,000,000 | 247,000,000 | 214,000,000 | 140,000,000 | 143,000,000 | 267,000,000 |
| Dividends paid | 245,000,000 | 349,000,000 | 514,000,000 | 597,000,000 | 614,000,000 | 750,000,000 | 897,000,000 | 900,000,000 | 903,000,000 | 908,000,000 |
| Assets | 99,714,000,000 | 104,185,000,000 | 108,781,000,000 | 109,002,000,000 | 123,038,000,000 | 174,064,000,000 | 182,906,000,000 | 189,368,000,000 | 204,230,000,000 | 225,106,000,000 |
| Liabilities | 89,406,000,000 | 93,371,000,000 | 97,679,000,000 | 97,207,000,000 | 110,045,000,000 | 154,746,000,000 | 165,137,000,000 | 169,970,000,000 | 184,448,000,000 | 200,727,000,000 |
| Stockholders' equity | 10,308,000,000 | 10,814,000,000 | 11,102,000,000 | 11,795,000,000 | 12,993,000,000 | 19,297,000,000 | 17,731,000,000 | 19,353,000,000 | 19,740,000,000 | 24,342,000,000 |
| Free cash flow | 1,095,000,000 | 1,760,000,000 | 1,616,000,000 | 1,467,000,000 | 1,204,000,000 | 1,815,000,000 | 3,813,000,000 | 2,517,000,000 | 1,693,000,000 | 2,215,000,000 |

### Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net margin | 27.05% | 34.55% | 35.27% | 33.59% | 22.40% | 30.90% | 37.49% | 21.88% | 19.55% | 21.45% |
| Return on equity | 6.91% | 10.97% | 12.55% | 11.96% | 6.29% | 6.71% | 12.62% | 10.08% | 9.83% | 9.08% |
| Return on assets | 0.71% | 1.14% | 1.28% | 1.29% | 0.66% | 0.74% | 1.22% | 1.03% | 0.95% | 0.98% |
| Liabilities / equity | 8.67 | 8.63 | 8.80 | 8.24 | 8.47 | 8.02 | 9.31 | 8.78 | 9.34 | 8.25 |

## As-reported value updates

1 tracked difference above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

Ledger: /company/HBAN/revisions/


## Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-04-30. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000049196.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

| Quarter | End date | Revenue | Net income | Diluted EPS | Method |
| --- | --- | ---: | ---: | ---: | --- |
| 2022-Q2 | 2022-06-30 |  |  | 0.35 | reported discrete quarter |
| 2022-Q3 | 2022-09-30 |  |  | 0.39 | reported discrete quarter |
| 2023-Q1 | 2023-03-31 |  |  | 0.39 | reported discrete quarter |
| 2023-Q2 | 2023-06-30 | 2,225,000,000 | 559,000,000 | 0.35 | reported discrete quarter |
| 2023-Q3 | 2023-09-30 | 2,313,000,000 | 547,000,000 | 0.35 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 2,350,000,000 | 243,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2024-Q1 | 2024-03-31 | 2,380,000,000 | 419,000,000 | 0.26 | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 2,476,000,000 | 474,000,000 | 0.30 | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 2,555,000,000 | 517,000,000 | 0.33 | reported discrete quarter |
| 2024-Q4 | 2024-12-31 | 2,510,000,000 | 530,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2025-Q1 | 2025-03-31 | 2,489,000,000 | 527,000,000 | 0.34 | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 2,556,000,000 | 536,000,000 | 0.34 | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 2,600,000,000 | 629,000,000 | 0.41 | reported discrete quarter |
| 2025-Q4 | 2025-12-31 | 2,665,000,000 | 519,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2026-Q1 | 2026-03-31 | 3,086,000,000 | 523,000,000 | 0.25 | reported discrete quarter |

## Filed narrative (10-K & 10-Q)

## Business

Verbatim Item 1 Business section from HBAN's latest 10-K: [/company/HBAN/business/](/company/HBAN/business/).

## Risk Factors

Verbatim Item 1A Risk Factors from HBAN's latest 10-K: [/company/HBAN/risk-factors/](/company/HBAN/risk-factors/).

## Latest quarter (10-Q)

Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/49196/000004919626000066/hban-20260630.htm

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Published MD&A gate trimmed front/tail over-capture.
Confidence: high
Filing date: 2026-07-28
Report date: 2026-06-30

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

INTRODUCTION

We are a multi-state diversified regional bank holding company organized under Maryland law in 1966 and

headquartered in Columbus, Ohio. Through the Bank, we are committed to making people’s lives better, helping

businesses thrive, and strengthening the communities we serve, and we have been servicing the financial needs of

our customers since 1866. Through our subsidiaries, we provide full-service commercial and consumer deposit,

lending, and other banking and financial services. These include, but are not limited to, payments, mortgage

banking, direct and indirect consumer financing, investment banking, capital markets, advisory, equipment

financing, distribution finance, investment management, trust, brokerage, insurance, and other financial products

and services. As of June 30, 2026, we operated over 1,400 branches in 21 states, with our Commercial and Vehicle

Finance businesses delivering expertise nationally.

This MD&A provides information we believe necessary for understanding our financial condition, changes in

financial condition, results of operations, and cash flows. This MD&A provides only material updates to the MD&A

included in our Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Annual Report on

Form 10-K”), and therefore, should be read in conjunction with the 2025 Annual Report on Form 10-K. This MD&A

should also be read in conjunction with the Unaudited Consolidated Financial Statements, Notes to Unaudited

## Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/49196/000004919626000015/hban-20251231.htm
Complete FY 2025 MD&A: /company/HBAN/mda/fy2025/

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture.
Confidence: high
Filing date: 2026-02-13
Report date: 2025-12-31

Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations

INTRODUCTION

This MD&A provides information we believe necessary for understanding our financial condition, changes in financial condition, results of operations, and cash flows. The MD&A should be read in conjunction with the Consolidated Financial Statements, Notes to Consolidated Financial Statements, and other information contained in this report. The forward-looking statements in this section and other parts of this report involve assumptions, risks, uncertainties, and other factors, including statements regarding our plans, objectives, goals, strategies, and financial performance. Our actual results could differ materially from the results anticipated in these forward-looking statements as a result of factors set forth under the caption “Forward-Looking Statements” and those set forth in “Item 1A: Risk Factors”.

In this MD&A we refer to FTE net interest income and FTE total revenue. These financial measures are not required by, or calculated in accordance with GAAP and may not be calculated the same as similarly titled measures used by other companies. These financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. For a further description of these non-GAAP financial measures, see the “Non-GAAP Financial Measures” within the “Additional Disclosures” section below.

EXECUTIVE OVERVIEW

Acquisitions and Divestitures

Veritex Acquisition

Effective October 20, 2025, Huntington completed the acquisition of Veritex Holdings, Inc. (“Veritex”), a bank holding company headquartered in Dallas, Texas, whereby Veritex merged with and into Huntington, with Huntington as the surviving entity. Upon completion of the merger, Huntington issued 107 million shares of its common stock to Veritex shareholders of record as of the merger date, in addition to 1 million shares issued upon the conversion of certain Veritex equity awards, resulting in total consideration from the transaction of $1.7 billion. Historical periods prior to October 20, 2025 reflect results of legacy Huntington operations. Subsequent to closing, results reflect all combined post-acquisition activity. For further information, refer to Note 3 - “Business Combinations” of the Notes to Consolidated Financial Statements.

Cadence Acquisition

Effective February 1, 2026, Huntington completed its previously announced acquisition of Cadence Bank (“Cadence”), a regional bank headquartered in Houston, Texas and Tupelo, Mississippi, whereby Cadence merged with and into Huntington National Bank, with Huntington National Bank as the surviving bank. Under the terms of the agreement, Huntington issued 2.475 shares for each outstanding share of Cadence in a 100% stock transaction. Based on Huntington’s closing price of $17.48 as of January 30, 2026, the consideration is valued at approximately $8.1 billion. Each outstanding share of 5.50% Series A Non-Cumulative Perpetual Preferred Stock of Cadence was converted into the right to receive 1/1000 of a share of a newly created 5.50% Series L Non-Cumulative Perpetual Preferred Stock of Huntington. As of December 31, 2025, Cadence had $54 billion in assets, including $37 billion in loans, and $44 billion in deposits.

2025 Form 10-K 51

Table of Contents

2025 Financial Performance Review

Selected Financial Data

[[GREPCENT_TABLE]]
[["Table 1 - Selected Year-to-Date Income Statement Data"],["","Year Ended December 31,"],["","","","Change from 2024","","","","Change from 2023"],["(amounts in millions, except per share data)","2025","","Amount","","Percent","","2024","","Amount","","Percent","","2023"],["Interest income","$","10,310","","$","389","","","4","%","","$","9,921","","$","1,005","","","11","%","","$","8,916"],["Interest expense","4,319","","(257)","","","(6)","","","4,576","","1,099","","","32","","","3,477"],["Net interest income","5,991","","646","","","12","","","5,345","","(94)","","","(2)","","","5,439"],["Provision for credit losses","463","","43","","","10","","","420","","18","","","4","","","402"],["Net interest income after provision for credit losses","5,528","","603","","","12","","","4,925","","(112)","","","(2)","","","5,037"],["Noninterest income","2,175","","135","","","7","","","2,040","","119","","","6","","","1,921"],["Noninterest expense","5,015","","453","","","10","","","4,562","","(12)","","","\u2014","","","4,574"],["Income before income taxes","2,688","","285","","","12","","","2,403","","19","","","1","","","2,384"],["Provision for income taxes","459","","16","","","4","","","443","","30","","","7","","","413"],["Income after income taxes","2,229","","269","","","14","","","1,960","","(11)","","","(1)","","","1,971"],["Income attributable to non-controlling interest","18","","(2)","","","(10)","","","20","","\u2014","","","\u2014","","","20"],["Net income attributable to Huntington","2,211","","271","","","14","","","1,940","","(11)","","","(1)","","","1,951"],["Dividends on preferred shares","124","","(10)","","","(7)","","","134","","(8)","","","(6)","","","142"],["Impact of preferred stock redemptions and repurchases","\u2014","","(5)","","","NM","","5","","13","","","NM","","(8)"],["Net income applicable to common shares","$","2,087","","$","286","","","16","%","","$","1,801","","$","(16)","","","(1)","%","","$","1,817"],["Average common shares\u2014basic","1,479","","28","","","2","%","","1,451","","5","","","\u2014","%","","1,446"],["Average common shares\u2014diluted","1,505","","29","","","2","","","1,476","","8","","","1","","","1,468"],["Net income per common share\u2014basic","$","1.41","","$","0.17","","","14","","","$","1.24","","$","(0.02)","","","(2)","","","$","1.26"],["Net income per common share\u2014diluted","1.39","","0.17","","","14","","","1.22","","(0.02)","","","(2)","","","1.24"],["Cash dividends declared per common share","0.62","","\u2014","","","\u2014","","","0.62","","\u2014","","","\u2014","","","0.62"],["Return on average assets","1.05","%","","","","","","0.99","%","","","","","","1.04","%"],["Return on average common shareholders\u2019 equity","10.8","","","","","","10.4","","","","","","11.2"],["Return on average tangible common shareholders\u2019 equity (1)","15.7","","","","","","15.7","","","","","","17.6"],["Net interest margin (2)","3.13","","","","","","3.00","","","","","","3.19"],["Efficiency ratio (3)","59.9","","","","","","60.5","","","","","","61.0"],["Revenue and Net Interest Income\u2014FTE (Non-GAAP)"],["Net interest income","$","5,991","","$","646","","","12","%","","$","5,345","","$","(94)","","","(2)","%","","$","5,439"],["FTE adjustment (2)","65","","12","","","23","","","53","","11","","","26","","","42"],["Net interest income, FTE (non-GAAP) (2)","6,056","","658","","","12","","","5,398","","(83)","","","(2)","","","5,481"],["Noninterest income","2,175","","135","","","7","","","2,040","","119","","","6","","","1,921"],["Total revenue, FTE (non-GAAP) (2)","$","8,231","","$","793","","","11","%","","$","7,438","","$","36","","","\u2014","%","","$","7,402"]]
[[/GREPCENT_TABLE]]

(1)    Net income applicable to common shares excluding expense for amortization of intangibles for the period divided by average tangible common shareholders’ equity. Average tangible common shareholders’ equity equals average total common shareholders’ equity less average intangible assets and goodwill. Expense for amortization of intangibles and average intangible assets are net of deferred taxes and calculated assuming a 21% tax rate.

(2)    Calculated on an FTE basis, which represents a non-GAAP measure, assuming a 21% tax rate.

(3)    Noninterest expense less amortization of intangibles divided by the sum of FTE net interest income and noninterest income excluding securities gains (losses).

52 Huntington Bancshares Incorporated

Table of Contents

Summary of Results

In 2025, we reported net income of $2.2 billion, or $1.39 per diluted common share, compared with net income in 2024 of $1.9 billion, or $1.22 per diluted common share. The current year reported net income was impacted by acquisition-related expenses totaling $168 million, or $129 million after tax, which reduced diluted earnings by $0.09 per common share.

Net interest income was $6.0 billion in 2025, an increase of $646 million, or 12%, from 2024. FTE net interest income, a non-GAAP financial measure, increased $658 million, or 12%, from 2024. The increase in FTE net interest income reflected a 13 basis point increase in the FTE NIM to 3.13% and a $13.9 billion, or 8%, increase in average earning assets, partially offset by a $12.9 billion, or 9%, increase in average interest-bearing liabilities. The NIM increase was primarily due to a decrease in the cost of funding, partially offset by a decrease in yields on earning assets and net hedging activity.

The provision for credit losses increased $43 million, or 10%, to $463 million for 2025. The ACL was $2.7 billion, or 1.83% of total loans and leases, at December 31, 2025, compared to $2.4 billion, or 1.88% of total loans and leases, at December 31, 2024. The increase in the ACL was driven by current year loan and lease growth, in addition to an ACL recorded for loans acquired in the Veritex transaction, partially offset by a decrease in the overall ACL coverage ratio.

Noninterest income was $2.2 billion, an increase of $135 million, or 7%, from the prior year, driven by a $24 million gain on the sale of a portion of our trust and custody business and increases in customer deposit and loan fees, wealth and asset management revenue, payments and cash management revenue, and capital markets and advisory fees, partially offset by an increase in net losses on sales of securities. Noninterest expense was $5.0 billion, an increase of $453 million, or 10%, from the prior year primarily due to higher personnel costs and outside data processing and other services, in addition to $168 million of acquisition-related expenses, partially offset by lower deposit insurance expense driven by a reduction in the amount of expense associated with the FDIC DIF special assessment due to ongoing adjustments to uninsured deposit losses by the FDIC.

Consolidated Balance Sheet and Capital Ratios

Total assets at December 31, 2025 were $225.1 billion, an increase of $20.9 billion, or 10%, compared to December 31, 2024. The increase in total assets was driven by $10.3 billion of organic loan growth and $9.3 billion of loans acquired as a result of the completion of the Veritex acquisition. Total liabilities at December 31, 2025 were $200.7 billion, an increase of $16.3 billion, or 9%, compared to December 31, 2024. The increase in total liabilities was largely driven by $10.8 billion of liabilities assumed as a result of the completion of the Veritex acquisition and organic deposit growth, partially offset by the run-off of certain higher-cost Veritex deposits.

The tangible common equity to tangible assets ratio increased to 7.1% at December 31, 2025, compared to 6.1% at December 31, 2024, primarily due to an increase in tangible common equity from earnings, net of dividends, an improvement in AOCI, and the net impact of the Veritex acquisition, partially offset by an increase in tangible assets. The CET1 risk-based capital ratio was 10.4% at December 31, 2025, down from 10.5% at December 31, 2024, with the decrease primarily due to an increase in risk-weighted assets and the CECL transition adjustment, partially offset by current period earnings, net of dividends.

2025 Form 10-K 53

Table of Contents

Business Overview

General

Our general business objectives are to:

•Deliver our Culture, Purpose, and Vision through a Differentiated Operating Model;

•Build on our vision to be the leading People-First, Customer-Centered bank in the country;

•Deliver top quartile performance through sust

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A: /company/HBAN/mda/fy2025/
All MD&A years: /company/HBAN/mda/


## MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

- [FY 2024 MD&A](/company/HBAN/mda/fy2024/): filed 2025-02-14; accession 0000049196-25-000020 (https://www.sec.gov/Archives/edgar/data/49196/000004919625000020/hban-20241231.htm)
- [FY 2023 MD&A](/company/HBAN/mda/fy2023/): filed 2024-02-16; accession 0000049196-24-000020 (https://www.sec.gov/Archives/edgar/data/49196/000004919624000020/hban-20231231.htm)
- [FY 2022 MD&A](/company/HBAN/mda/fy2022/): filed 2023-02-17; accession 0000049196-23-000020 (https://www.sec.gov/Archives/edgar/data/49196/000004919623000020/hban-20221231.htm)
- [FY 2021 MD&A](/company/HBAN/mda/fy2021/): filed 2022-02-18; accession 0000049196-22-000023 (https://www.sec.gov/Archives/edgar/data/49196/000004919622000023/hban-20211231.htm)




## Macro cross-references

Indicators mapped to this company's SIC classification (industry 6021 National Commercial Banks) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

- [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate
- [DFEDTARU](/indicator/DFEDTARU/): Federal Funds Target Range - Upper Limit
- [DGS2](/indicator/DGS2/): Market Yield on U.S. Treasury Securities at 2-Year Constant Maturity
- [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- [T10Y2Y](/indicator/T10Y2Y/): 10-Year Treasury Constant Maturity Minus 2-Year Treasury Constant Maturity

Macro-to-micro threads including this sector: [Interest rates & the Fed](/thread/interest-rates-fed/), [Money & trade](/thread/money-trade/), [Consumer & credit](/thread/consumer-credit/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/).

All macro indicators: /indicators/


## For LLMs & downloads

Markdown twin: /company/HBAN.md · JSON record: /company/HBAN.json · verified financials: /company/HBAN/financials.json / /company/HBAN/financials.csv · machine TOC for the whole site: /llms.txt
